Stabilization of Mood From Below Versus Above Baseline in Bipolar Disorder: A New Nomenclature
The DOI matches its Crossref record.
Abstract
Management of bipolar disorder has traditionally emphasized the acute treatment of mania. Although acute treatment of mania is a critical aspect of care, this emphasis has tended to overshadow other important phases of bipolar disorder, such as depression, hypomania, and subsyndromal symptoms. We offer a reconceptualization of bipolar disorder that highlights unmet needs and the importance of differential spectra of efficacy. In this reconceptualization, bipolar disorder can be viewed as an aberration of mood, behavior, and cognition from baseline (euthymia). "Below baseline" is characterized by depression and subsyndromal depression. "Above baseline" is characterized by mania, mixed states, hypomania, and subsyndromal mood elevation. In contrast to the treatment options for mania, the options for depression are limited. This new nomenclature emphasizes the need to develop mood stabilizers that possess the ability to stabilize mood "from below baseline," either alone or in combination with other agents. In this article, the treatment options for bipolar disorder, with a focus on depression and rapid cycling, are discussed according to this new conceptualization of management from below and above baseline.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Responders to lamotrigine have a predominantly depressive polarity as well as comorbid anxiety.420, 421”
Citations
Cites
Still being checked.
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationGoodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Cognitive Function Across Manic or Hypomanic, Depressed, and Euthymic States in Bipolar Disorder
Martínez-Arán, A., Vieta, E., Reinares, M., Colom, F., Torrent, C., Sánchez-Moreno, J., Benabarre, A., Goikolea, J. M., Comes, M., & Salamero, M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.262 · Cited by 1,103
McIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., López-Jaramillo, C., Kessing, L. V., Malhi, G. S., Nierenberg, A. A., Rosenblat, J. D., Majeed, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31544-0 · Cited by 1,047
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationWhat Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862
Role of GABA in anxiety and depression
Kalueff, A. V., & Nutt, D. J. (2007) · Depression and Anxiety · doi:10.1002/da.20262 · Cited by 534
Goodwin, G., & Consensus Group of the British Association for Psychopharmacology (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102919 · Cited by 444
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.770551 · Cited by 421
Goodwin, G. M. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017002003 · Cited by 390
Clinical and therapeutic implications of predominant polarity in bipolar disorder
Colom, F., Vieta, E., Daban, C., Pacchiarotti, I., & Sánchez-Moreno, J. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.01.032 · Cited by 301
Calabrese, J. R., Shelton, M. D., Rapport, D. J., Youngstrom, E. A., Jackson, K., Bilali, S., Ganocy, S. J., & Findling, R. L. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2152 · Cited by 252
Self-citationGender differences in a cohort study of 604 bipolar patients: The role of predominant polarity
Nivoli, A. M. A., Pacchiarotti, I., Rosa, A. R., Popovic, D., Murru, A., Valenti, M., Bonnin, C. M., Grande, I., Sanchez-Moreno, J., Vieta, E., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.055 · Cited by 208
Perugi, G., Medda, P., Toni, C., Mariani, M., Socci, C., & Mauri, M. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161017233642 · Cited by 167
“To be considered a mood stabilizer, an agent ought to decrease the frequency or severity of any type of episode in BD without worsening the frequency or severity of other types of episodes [111, 112].”
BackgroundPsychoeducation: improving outcomes in bipolar disorder
Colom, F., & Lam, D. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.06.002 · Cited by 147
Grunze, H., Kasper, S., Goodwin, G., Bowden, C., Mo¨ller, H.-J., & WFSBP Task Force on Treatment Guide (2004) · The World Journal of Biological Psychiatry · doi:10.1080/15622970410029924 · Cited by 144
Anand, A., Barkay, G., Dzemidzic, M., Albrecht, D., Karne, H., Zheng, Q.-H., Hutchins, G. D., Normandin, M. D., & Yoder, K. K. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00936.x · Cited by 139
Wong, E. H. F., Yocca, F., Smith, M. A., & Lee, C.-M. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000866 · Cited by 134
Colom, F., & Vieta, E. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00136.x · Cited by 129
Macfarlane, A., & Greenhalgh, T. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1842-x · Cited by 136
Potential Mechanisms of Action of Lamotrigine in the Treatment of Bipolar Disorders
Ketter, T. A., Manji, H. K., & Post, R. M. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000088915.02635.e8 · Cited by 117
Self-citationPredominant polarity in bipolar disorder: Diagnostic implications
Rosa, A. R., Andreazza, A. C., Kunz, M., Gomes, F. A., Santin, A., Sánchez‐Moreno, J., Reinares, M., Colom, F., Vieta, E., & Kapczinski, F. P. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.07.021 · Cited by 123
PPAR-γ Agonism as a Modulator of Mood: Proof-of-Concept for Pioglitazone in Bipolar Depression
Kemp, D. E., Schinagle, M., Gao, K., Conroy, C., Ganocy, S. J., Ismail-Beigi, F., & Calabrese, J. R. (2014) · CNS Drugs · doi:10.1007/s40263-014-0158-2 · Cited by 104
Self-citationEvaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania
Arban, R., Maraia, G., Brackenborough, K. T., Winyard, L. A., Wilson, A. W., Gerrard, P. A., & Large, C. H. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.08.015 · Cited by 93
Li, X., Tenebäck, C. C., Nahas, Z. H., Kozel, F. A., Large, C. H., Cohn, J., Bohning, D. E., & George, M. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300452 · Cited by 100
A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder
Hirschfeld, R. M. A., & Kasper, S. F. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004651 · Cited by 100
Bipolar depression: issues in diagnosis and treatment
Thase, M. E. (2005) · Harvard Review of Psychiatry · doi:10.1080/10673220500326425 · Cited by 89
Mania and depression. Mixed, not stirred
Pacchiarotti, I., Mazzarini, L., Kotzalidis, G. D., Valentí, M., Nivoli, A., Sani, G., Torrent, C., Murru, A., Sánchez‐Moreno, J., Patrizi, B., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.037 · Cited by 97
Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia?
Ketter, T. A., Wang, P. W., Becker, O. V., Nowakowska, C., & Yang, Y.-S. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00099-2 · Cited by 95
Self-citationGenetic Influences on Response to Mood Stabilizers in Bipolar Disorder: Current Status of Knowledge
RYBAKOWSKI, J. K. (2013) · CNS Drugs · doi:10.1007/s40263-013-0040-7 · Cited by 95
Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer
Prabhavalkar, K. S., Poovanpallil, N. B., & Bhatt, L. K. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00242 · Cited by 70
Comparative analysis of the effects of four mood stabilizers in SH‐SY5Y cells and in primary neurons
Daniel, E. D., Mudge, A. W., & Maycox, P. R. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00164.x · Cited by 80
The potential role of lamotrigine in schizophrenia
Large, C. H., Webster, E. L., & Goff, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0020-9 · Cited by 69
Safety and tolerability of emerging pharmacological treatments for bipolar disorder
Dünner, D. L. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00235.x · Cited by 74
Fornaro, M., McCarthy, M. J., De Berardis, D., Pasquale, D., Martino, Colicchio, Cattaneo, D'Angelo, Fornaro, P., & Tabaton (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s41557 · Cited by 67
Poyurovsky, M., Glick, I., & Koran, L. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881108099215 · Cited by 65
Maj, M., Pirozzi, R., Magliano, L., & Bartoli, L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1711 · Cited by 61
‘Bipolar Missed States’: The Diagnosis and Clinical Salience of Bipolar Mixed States
Berk, M., Dodd, S., & Malhi, G. S. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01557.x · Cited by 59
The Diverse Roles of Anticonvulsants in Bipolar Disorders
Ketter, T. A., Wang, P. W., Becker, O. V., Nowakowska, C., & Yang, Y.-S. (2003) · Annals of Clinical Psychiatry · doi:10.1023/a:1024636309185 · Cited by 62
Self-citationEfficacy and Tolerability of Pharmacotherapies for Borderline Personality Disorder
Bellino, S., Paradiso, E., & Bogetto, F. (2008) · CNS Drugs · doi:10.2165/00023210-200822080-00005 · Cited by 60
Post, R. M., Ketter, T. A., Uhde, T. W., & Ballenger, J. C. (2007) · CNS Drugs · doi:10.2165/00023210-200721010-00005 · Cited by 72
Self-citationLatest maintenance data on lamotrigine in bipolar disorder
Calabrese, J. R., Vieta, E., & Shelton, M. D. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00079-8 · Cited by 63
Self-citationCirillo, P. C., Passos, R. B. F., Bevilaqua, M. C. D. N., López, J. R. R. A., & Nardi, A. E. (2012) · Revista Brasileira de Psiquiatria · doi:10.1016/j.rbp.2012.04.010 · Cited by 55
Rybakowski, J. K., Permoda-Osip, A., & Bartkowska-Sniatkowska, A. (2017) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2017.1297834 · Cited by 52
Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder
Grunze, A., Amann, B. L., & Grunze, H. (2021) · Medicina · doi:10.3390/medicina57050433 · Cited by 63
Besag, F., Vasey, M. J., Sharma, A., & Lam, I. C. H. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211045870 · Cited by 62
Zhang, W., Xiao, Y., Sun, H., Patino, L. R., Tallman, M. J., Weber, W. A., Adler, C. M., Klein, C. C., Strawn, J. R., Nery, F. G., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0120-y · Cited by 47
Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?
Ketter, T. A., Citrome, L., Wang, P. W., Culver, J. L., & Srivastava, S. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01645.x · Cited by 49
Self-citationBipolar depression: Diagnostic and treatment considerations
Thase, M. E. (2006) · Development and Psychopathology · doi:10.1017/s0954579406060585 · Cited by 55
RYBAKOWSKI, J. K. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.005 · Cited by 50
Two generations of mood stabilizers
Rybakowski, J. K. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570700795x · Cited by 46
Li, X., Large, C. H., Ricci, R., Taylor, J. J., Nahas, Z. H., Bohning, D. E., Morgan, P. S., & George, M. S. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.04.012 · Cited by 47
Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder
Muzina, D. J., Elhaj, O., Gajwani, P., Gao, K., & Calabrese, J. R. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00523.x · Cited by 49
Self-citationWhat we know and what we don't know about the treatment of schizoaffective disorder
Murru, A., Pacchiarotti, I., Nivoli, A., Grande, I., Colom, F., & Vieta, E. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.001 · Cited by 43
Antidepressant Properties of Anticonvulsant Drugs for Bipolar Disorder
Ernst, C. L., & Goldberg, J. F. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00011 · Cited by 44
Mood stabilizers for patients with bipolar disorder: the state of the art
Altamura, A. C., Lietti, L., Dobrea, C., Benatti, B., Arici, C., & Dell’Osso, B. M. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.181 · Cited by 39
Cookson, J., Keck, P. E., Ketter, T. A., & Macfadden, W. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3280119dfb · Cited by 39
Self-citationMood stabilization in the treatment of bipolar disorder: focus on quetiapine
Vieta, E. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.689 · Cited by 44
Antiepileptic drugs in psychiatry—focus on randomized controlled trial
Muzina, D. J., El-Sayegh, S., & Calabrese, J. R. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00080-3 · Cited by 39
Self-citationPharmacotherapy of bipolar depression: An update
Thase, M. E. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0055-6 · Cited by 42
Heartbeat Complexity Modulation in Bipolar Disorder during Daytime and Nighttime
Nardelli, M., Lanatà, A., Bertschy, G., Scilingo, E. P., & Valenza, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-18036-z · Cited by 33
Nivoli, A., Colom, F., Pacchiarotti, I., Murru, A., Scott, J. L., Valentí, M., Mazzarini, L., Bonnín, C. D. M., Sánchez‐Moreno, J., Serretti, A., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.015 · Cited by 35
Bipolar disorder How far are we from a rigorous definition and effective management?
Emilien, G., Septien, L., Brisard, C., Corruble, E., & Bourin, M. (2007) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.005 · Cited by 31
A Genome-Wide Association Study of Amygdala Activation in Youths With and Without Bipolar Disorder
Liu, X., Akula, N., Skup, M., Brotman, M. A., Leibenluft, E., & McMahon, F. J. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2009.10.006 · Cited by 35
Rapid-cycling bipolar disorder
Elhaj, O., & Calabrese, J. R. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544019.004 · Cited by 31
Self-citationPharmacogenomics of Bipolar Disorder
Severino, G., Squassina, A., Costa, M. F., Pisanu, C., Calza, S., Alda, M., Zompo, M. D., & Manchia, M. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.51 · Cited by 33
Bipolar disorder: Improving diagnosis and optimizing integrated care
Culver, J. L., Arnow, B. A., & Ketter, T. A. (2006) · Journal of Clinical Psychology · doi:10.1002/jclp.20333 · Cited by 38
Self-citationMood stabilizers in pregnancy and lactation
Grover, S., & Avasthi, A. (2015) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.161498 · Cited by 33
Lamotrigine: when and where does it act in affective disorders? A systematic review
Amann, B. L., Born, C., Crespo, J. M., Pomarol‐Clotet, E., & McKenna, P. J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110376695 · Cited by 30
The role of lamotrigine in the management of bipolar disorder
Ng, F., Hallam, K. T., Lucas, N., & Berk, M. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a920 · Cited by 43
Quetiapine monotherapy for bipolar depression
Thase, M. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1162 · Cited by 34
Mood Stabilizers and Treatment Adherence in Bipolar Disorder: Addressing Adverse Events
Berk, M., & Berk, L. (2003) · Annals of Clinical Psychiatry · doi:10.1023/b:acli.0000008175.32403.8e · Cited by 30
New medication treatment options for bipolar disorders
Ketter, T. A., Wang, P. W., Nowakowska, C., & Marsh, W. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00410.x · Cited by 36
Self-citationKleindienst, N., Severus, W. E., & Greil, W. (2007) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000224788.21406.c8 · Cited by 26
Lamotrigine in the treatment of bipolar disorder
Bhagwagar, Z., & Goodwin, G. M. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.8.1401 · Cited by 26
Etanercept, anticytokines and mania
Kaufman, K. R. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200507000-00008 · Cited by 27
Lamotrigine: a depression mood stabiliser
HERMAN, E. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.03.003 · Cited by 25
Differential modulation of intracellular Ca2+ responses in B lymphoblasts by mood stabilizers
Perova, T., Kwan, M., Li, P. P., & Warsh, J. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000261 · Cited by 25
Effectiveness of lamotrigine in bipolar disorder in a clinical setting
Ketter, T. A., Brooks, J. O., Hoblyn, J. C., Champion, L. M., Nam, J. Y., Culver, J. L., Marsh, W., & Bonner, J. C. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.02.007 · Cited by 27
Self-citationKorean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines
Jeong, J., Bahk, W., Woo, Y. S., Lee, J. G., Kim, M.-D., Sohn, I., Shim, S.-H., Jon, D., Seo, J. S., Kim, W. K., et al. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.2.155 · Cited by 25
Antiepileptic Drugs and Mood Stability
Amann, B. L., Grunze, H., Vieta, E., & Trimble, M. (2007) · Clinical EEG and Neuroscience · doi:10.1177/155005940703800214 · Cited by 27
Li, X., Ricci, R., Large, C. H., Anderson, B. S., Nahas, Z. H., Bohning, D. E., & George, M. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1786-y · Cited by 25
Matching the Bipolar Patient and the Mood Stabilizer
Gelenberg, A. J., & Pies, R. W. (2003) · Annals of Clinical Psychiatry · doi:10.1023/b:acli.0000008174.46414.a4 · Cited by 27
Woo, Y. S., Yoon, B.-H., Song, J.-H., Seo, J. S., Nam, B., Lee, K., Lee, J., Jung, Y., Kim, M.-D., Lee, J. G., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227217 · Cited by 23
Bipolar (Spectrum) Disorder and Mood Stabilization: Standing at the Crossroads?
Fruyt, J. D., & Demyttenaere, K. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000097966 · Cited by 27
When Do Antidepressants Worsen the Course of Bipolar Disorder?
Goldberg, J. F. (2003) · Journal of Psychiatric Practice · doi:10.1097/00131746-200305000-00002 · Cited by 22
Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine
Large, C. H., Daniel, E. D., Li, X., & George, M. S. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371080 · Cited by 22
The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders
Bourin, M., & Prica, C. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.03.001 · Cited by 25
Goldberg, J. F., Calabrese, J. R., Saville, B. R., Frye, M. A., Ketter, T. A., Suppes, T. M., Post, R. M., & Goodwin, F. K. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04381 · Cited by 22
Self-citationTreatment of acute mania?from clinical trials to recommendations for clinical practice
Bourin, M., Lambert, O., & Guitton, B. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.657 · Cited by 20
New Directions in Brain Imaging Research in Functional Gastrointestinal Disorders
Ringel, Y. (2006) · Digestive Diseases · doi:10.1159/000092881 · Cited by 20
The Role of Electroconvulsive Therapy in the Treatment of Severe Bipolar Mixed State
Perugi, G., Medda, P., Barbuti, M., Novi, M., & Tripodi, B. (2019) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2019.10.010 · Cited by 22
Newer Prophylactic Agents for Bipolar Disorder and Their Influence on Suicidality
Born, C., Dittmann, S., Post, R. M., & Grunze, H. (2005) · Archives of Suicide Research · doi:10.1080/13811110590929541 · Cited by 19
New Anticonvulsant Medication Uses in Bipolar Disorder
Wang, P. W., Ketter, T. A., Becker, O. V., & Nowakowska, C. (2003) · CNS Spectrums · doi:10.1017/s1092852900028704 · Cited by 19
Self-citationRecent advances in the understanding and management of bipolar disorder in adults
RYBAKOWSKI, J. K. (2017) · F1000Research · doi:10.12688/f1000research.12329.1 · Cited by 20
Maintenance therapy for bipolar disorder: current and future management options
Vieta, E. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.6.s35 · Cited by 18
Becker, O., Rasgon, N., Marsh, W., Glenn, T., & Ketter, T. A. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00146.x · Cited by 16
Self-citationTreatment of bipolar depression: current status, continued challenges, and the STEP-BD approach
Thase, M. E., Bhargava, M., & Sachs, G. S. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00029-7 · Cited by 17
Role of endogenous ouabain in the etiology of bipolar disorder
El‐Mallakh, R. S., Gao, Y., & You, P. (2021) · International Journal of Bipolar Disorders · doi:10.1186/s40345-020-00213-1 · Cited by 14
Endogenous Cardiac Steroids in Bipolar Disorder: State of the Art
El‐Mallakh, R. S., Sampath, V. P., Horesh, N., & Lichtstein, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031846 · Cited by 14
Metadata
- Authors
- Ketter, T., & Calabrese, J. R.
- Affiliations
- Stanford Medicine (US)
- Stanford University (US)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-02-15
- Volume
- 63
- Issue
- 2
- Pages
- 146-151
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2046597861
- Cited by
- 161
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 1 · 2013: 8 · 2012: 6
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Keywords
- bipolar disorder, mood stabilization, euthymia, depression, subthreshold depression, mania, hypomania, mixed states, rapid cycling, mood stabilizers
- MeSH terms
- Lamotrigine, Affect, Antidepressive Agents, Bipolar Disorder, Carbamazepine, Clinical Trials as Topic, Double-Blind Method, Electroconvulsive Therapy, Humans, Lithium, Models, Psychological, Terminology as Topic, Antipsychotic Agents, Triazines, Valproic Acid, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.